Several epidemiological studies have demonstrated that elevated circulating PAI-1 levels and PAI-1 activity are an important feature of or even a marker for the development of metabolic disturbances including obesity, type 2 diabetes, and metabolic syndrome [59,60,61]. This evidence concerns the gene SERPINE1 and metabolic syndrome.